Abstract 1796: A targeted RNA-seq assay to measure activating ER mutations and ER/PR-associated gene expression predicts sensitivity to endocrine therapy for metastatic breast cancer
Cancer Res (2017) 77 (13_Supplement): 1796.
Currently there are no citedby results. Try again later.
